Similar articles

• N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.

  McCaffrey RA, Saunders C, Hensel M, Stamatatos L. McCaffrey RA, et al. J Virol. 2004 Apr;78(7):3279-95. doi: 10.1128/jvi.78.7.3279-3295.2004. J Virol. 2004. PMID: 15016849 Free PMC article.
• AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.

  Emini EA, Koff WC. Emini EA, et al. Science. 2004 Jun 25;304(5679):1913-4. doi: 10.1126/science.1100368. Science. 2004. PMID: 15218131 No abstract available.
• Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

  Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E. Derdeyn CA, et al. J Virol. 2000 Sep;74(18):8358-67. doi: 10.1128/jvi.74.18.8358-8367.2000. J Virol. 2000. PMID: 10954535 Free PMC article.
• Antiviral effects of CD4 derivatives.

  Capon DJ, Ward RH. Capon DJ, et al. Curr Opin Immunol. 1989-1990 Feb;2(3):433-8. doi: 10.1016/0952-7915(89)90156-8. Curr Opin Immunol. 1989. PMID: 2576772 Review. No abstract available.
• [Current advances in HIV pathogenesis. Results of therapy and vaccine development].

  Wagner R, Mayer J, Wolf H. Wagner R, et al. Dtsch Med Wochenschr. 1995 May 19;120(20):728-36. doi: 10.1055/s-2008-1055401. Dtsch Med Wochenschr. 1995. PMID: 7758413 Review. German. No abstract available.